Thursday , July 29 2021

Pfizer will deliver half as many doses of covid-19 vaccine this year as originally announced



Modern plans to provide 100 to 125 million doses of covid-19 vaccine in the first quarter of next year, most of which will go to the United States.  Photo: Reuters

Modern plans to provide 100 to 125 million doses of covid-19 vaccine in the first quarter of next year, most of which will go to the United States. Photo: Reuters

As a Pfizer spokeswoman told the American Wall Street Journal, the company was forced to halve the target it had set for this year, mainly due to supply chain problems. To increase the purchase of raw materials for the production of vaccines, they need much more time than originally expected.

In addition, the results of the clinical phase of vaccine tests were available later than expected, which contributed to the delay, reports German Deutsche Wave (DW).

The vaccine is still being determined in the EU

Pfizer vaccine and BioNTecha it is said to be 95% effective and its general use has so far been approved in the UK and Bahrain.

The European Medicines Agency (EMA), which is responsible for verifying medicines and vaccines for the whole of the European Union (EU), including Slovenia, has carried out an ongoing review of several vaccines against covidu-19. The review is designed to quickly assess a potential drug or vaccine during a health crisis, enabling EMI to review data on an ongoing basis while clinical trials are still ongoing.

As a Pfizer spokeswoman told the American Wall Street Journal, the company was forced to halve the target it had set for this year, mainly due to supply chain problems.  Photo: Reuters

As a Pfizer spokeswoman told the American Wall Street Journal, the company was forced to halve the target it had set for this year, mainly due to supply chain problems. Photo: Reuters

The current Pfizer vaccine and BioNTecha, a vaccine from the American pharmaceutical company Moderna and a vaccine developed by AstraZeneca and Oxford University. On the application for a conditional approval for the sale of Pfizer and BioNTecha The EMA will decide on the permit for Modernino the vaccine on 12 January.

Modern intends to provide between 100 and 125 million doses of the vaccine during the first quarter of next year. covidu-19, most of whom will go to the United States.




Source link